She has been working as a scientific officer at Molecular Diagnostics and Translational Medicines since half a  decade. Her lab is a division of Pathology at Tata Memorial Hospital. Over these years, her work primarily  focuses on developing and standardizing, validating essential molecular diagnostics to be used for  personalized therapy.  

As a Scientific officer working in the Molecular Diagnostics laboratory, the primary vision includes Patient care  by providing accurate, reliable diagnosis and to accentuate the performance of the laboratory towards  achieving this goal on everyday basis. This includes developing new molecular assays which addresses the  following D; biomarker for diagnosis, P: predictive value for prognosis, C: indicator for chemo sensitivity/ MDR,  T: potential target for treatment, which will be accomplished on next gen sequencer platform by designing  comprehensive gene panels for various disease and to make available these facilities accessible to all.  

As one of the leading molecular diagnostic centers for solid tumors in the country, she has initiated a quality  assurance program for molecular Diagnostics Molecular Pathology Quality Assurance Program [MPQAP], this  initiative is taken up with purpose to develop method based proficiency testing for developing uniformity while  maintaining the Quality of the molecular diagnostics tests being performed and interpreted in this country in  collaboration with NCG.